SILVERARC CAPITAL MANAGEMENT, LLC – Apellis Pharmaceuticals, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$0
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -129.79K shares | -5.86M | $68.3 | 0 |
| Q2 2022 | share | Increase | +23.18% | 24.42K shares | 515K | $45.22 | 129.79K |
| Q1 2022 | share | Increase | 0.00% | 105.36K shares | 5.35M | $50.81 | 105.36K |
| Q3 2021 | share | Decrease | -100.00% | -7.00K shares | -443K | $32.96 | 0 |
| Q2 2021 | share | Increase | 0.00% | 7.00K shares | 443K | $63.2 | 7.00K |